---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-053319"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2023-11-15T23:59:59+00:00"
generated_at: "2026-06-08T01:56:29.652208+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences Q3 revenue down 6% to $8.9M; suspends FY 2023 guidance

## Summary
- Total revenues $8.9M vs $9.4M in Q3 2022 (-6.0%); global recurring rev $5.3M vs $5.8M.
- Net loss $1.1M ($0.03 loss per share) vs $1.0M loss in Q3 2022.
- Non-GAAP EBITDA improved to $1.0M from $0.6M; gross margin fell to 56% from 62%.
- Company suspends FY 2023 guidance following management change effective Oct 31, 2023.
- Dr. Dolev Rafaeli named CEO and Vice-Chairman, effective October 31, 2023.

## SEC filing metadata
- accession: 0001140361-23-053319
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2023-11-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036123053319/0001140361-23-053319-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036123053319/ef20014656_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-053319
- JSON: https://secwatch.observer/filing/0001140361-23-053319.json
- Plain text: https://secwatch.observer/filing/0001140361-23-053319.txt

## Key facts
- Earnings Releases
  STRATA Skin Sciences, Inc. reported the third fiscal quarter ended September 30, 2023 results: revenue $8.9 million, net income Net loss for the third quarter of 2023 was $1.1 million, or a loss of $0.03 per basic and diluted common share, EPS $0.03 per basic and diluted common share.
  - Period: the third fiscal quarter ended September 30, 2023
  - Revenue: $8.9 million
  - Net income: Net loss for the third quarter of 2023 was $1.1 million, or a loss of $0.03 per basic and diluted common share
  - EPS: $0.03 per basic and diluted common share
  - Result: reported results
  source text: conditions, today announced financial results for the third quarter ended September 30, 2023. Third Quarter 2023 and Recent Business Highlights: ● Total Revenues were $8.9 million compared to $9.4 million for the third quarter of 2022, a total decrease of 6.0%. ● Non-GAAP EBITDA improved to $1.0 million compared to $0.6 million for the third quarter of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000114036123053319/0001140361-23-053319-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.